Letters: A Word of Caution on Colchicine Study

We read with interest the article, “Colchicine Effective for Acute Pericarditis” by Lara C. Pullen, PhD (published online Oct. 31, 2013). It is important to note the limitation of this study for patients with rheumatic diseases—only a small proportion of patients had CTD, and hence this study cannot be generalized to patients that we treat as rheumatologists.

Gurjit S. Kaeley, MRCP
Division Chief Associate Professor of Medicine Rheumatology Fellowship
Program Director
Director of Musculoskeletal Ultrasound Division of Rheumatology
University of Florida College of Medicine Jacksonville

Discovered more than 3,000 years ago, colchicine is one of the oldest drugs still in use today. Like most old remedies, colchicine is a chemical substance found in many plants, most notably in colchicum autumnale, known as wild saffron or autumn crocus. It was mentioned in the oldest Egyptian medical text, Ebers Papyrus (circa 1550…

Patients with acute pericarditis who are treated with colchicine in combination with a traditional antiinflammatory therapy experience a significantly reduced rate of incessant or recurrent pericarditis. (posted Oct. 31)

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

One of the oldest treatment options in rheumatology, colchicine, may be an effective and inexpensive treatment to prevent complications in non-hospitalized patients with COVID-19, particularly in men, according to the results of large global study.

Letters: A Word of Caution on Colchicine Study

Colchicine: An Ancient Drug with Modern Uses

Colchicine Effective for Acute Pericarditis

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

International Study Finds Colchicine Promising as Outpatient Treatment for COVID-19

Related Articles